micro News and Research

RSS

Fibrogen reports FG-3019 Phase 2 study results for treatment of pancreatic cancer

FibroGen, Inc. today announced results from a Phase 2 open-label study of FG-3019, an investigational anti-fibrotic antibody, in combination with gemcitabine and erlotinib for the treatment of patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).

31 May 2014

PGFX Patent Holdings acquires proprietary methods, devices, intellectual property from Orogen Biosciences

On Friday, April 18th PGFX Patent Holdings, operating as Heritage Biosciences, LLC made an asset acquisition of proprietary methods, devices and intellectual property from Orogen Biosciences, Inc.

31 May 2014

Patents for new method to rid carpets and mattresses of harmful allergens that cause asthma

A team of researchers from the University of South Carolina received two patents for a new method to rid carpets, mattresses and other furniture of harmful allergens and pests that cause asthma.

28 May 2014

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

EKF, confirms scientific evidence as validation that soluble TNF Receptors 1 and 2 are strong biomarkers of progressive Diabetic Kidney Disease.

From EKF Diagnostics 23 May 2014

3D capillary device can increase production of high-quality liposomes

When the English author Sir Francis Bacon wrote "The world's a bubble" in 1629, it's a safe bet he wasn't thinking about microfluidics.

22 May 2014

Olive oil supplements may counteract adverse cardiovascular effects of exposure to air pollution

Taking olive oil supplements may counteract some of the adverse cardiovascular effects of exposure to air pollution, according to a new study presented at the 2014 American Thoracic Society International Conference.

20 May 2014

New ultra-sensitive nano-chip capable of detecting cancer at early stages

The majority of cancers are detected on the macroscopic level, when the tumor is already composed of millions of cancer cells and the disease is starting to advance into a more mature phase.

19 May 2014

OxThera granted new patents for treatment of hyperoxaluria

OxThera AB announced today that it has been granted two new US patents and one new Australian patent during the last year.

15 May 2014

Environmental researchers call for ban on cigarette filters

Ban cigarette filters. Start a deposit-return scheme for used butts. Hold manufacturers responsible for clean-ups. Place warnings on packets about the impact of simply flicking one's used cigarettes away.

7 May 2014

Mixing stem cells with clay to regenerate human tissue

Gels made from clay could provide an environment that would stimulate stem cells to regenerate damaged tissues such as bone, skin, heart, spinal cord, liver, pancreas and cornea.

5 May 2014

Six-way jet-in-air sorter from Beckman Coulter Life Sciences delivers simultaneous high-speed cell sorting and sub-micron particle detection

MoFlo Astrios EQ, a six-way jet-in-air sorter from Beckman Coulter Life Sciences, delivers patent pending enhanced dual forward scatter (eFSC) technology for simultaneous sorting and detection of particles from 200 nm to 30 µm in diameter. The instrument sets a new standard for flow cytometry core facilities, delivering high-speed cell sorting and micro-particle detection in a single package. Featuring detailed and precise forward scatter resolution, beadless drop sample handling and increased biosafety, Astrios EQ meets a range of analysis needs.

2 May 2014

Retinal measurements associated with Parkinson’s disease duration

The inner retinal layers in the eyes of patients with Parkinson’s disease are thinner than those of healthy people’s eyes, except for the inner nuclear layer, which is thicker, show the results of a prospective study involving the latest optical coherence tomography methods.

1 May 2014

NovaBay introduces new eye care product to help patients with eyelids irritation

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced that it is introducing a new eye care product, i-Lid Cleanser.

23 Apr 2014

Sprifermin reduces cartilage loss in patients with knee osteoarthritis

In a new study in patients with osteoarthritis (OA) of the knee, at 12 months, total femorotibial cartilage thickness loss was reduced in sprifermin (recombinant human fibroblast growth factor 18)-treated knees compared to placebo-treated knees, with effects being significant in the lateral femorotibial compartment but not in the central femorotibial compartment.

18 Apr 2014

OPKO Health enters into definitive agreement to acquire Inspiro Medical

OPKO Health, Inc. has entered into a definitive agreement to acquire Inspiro Medical Ltd., an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. Inspiro's Inspiromatic is a "smart" easy-to-use dry powder inhaler with several advantages over existing devices.

17 Apr 2014

Quantum Materials supplies metallic oxide particles to major Asian electronics conglomerate

Quantum Materials Corp. (OTCQB:QTMM) announced today shipping size-optimized metallic oxide particles to a major Asian electronics conglomerate.

10 Apr 2014

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

With just one month until 2014 Biotech China, experts, entrepreneurs and decision-makers from the international biotechnology industry will gather at the heart of the Chinese biotechnology industry on May 14-16th, 09:00 AM-06:00 PM in Nanjing China.

10 Apr 2014

Comprehensive genomic analysis of low-grade brain tumors sorts into three categories

Comprehensive genomic analysis of low-grade brain tumors sorts them into three categories, one of which has the molecular hallmarks and shortened survival of glioblastoma multiforme, the most lethal of brain tumors, researchers reported at the American Association for Cancer Research Annual Meeting 2014.

10 Apr 2014

Covaris' European subsidiary to commence operations on May 1, 2014

Covaris, Inc., an innovator in the life science tools and the clinical diagnostic market spaces, announced today that its European subsidiary, Covaris Ltd, which is located in the United Kingdom, will commence operations on May 1, 2014.

10 Apr 2014

Viewpoints: A 'misguided' debate; trying to figure out who's uninsured; the safety net for the middle class

Supporters of Obamacare are celebrating that the law is not an unmitigated disaster, just a mitigated one. As enrollment closed (for most) on March 31, the system passed 7 million exchange sign-ups.

9 Apr 2014

micro News and Research

Fibrogen reports FG-3019 Phase 2 study results for treatment of pancreatic cancer

PGFX Patent Holdings acquires proprietary methods, devices, intellectual property from Orogen Biosciences

Patents for new method to rid carpets and mattresses of harmful allergens that cause asthma

EKF affirms that novel sTNFR1/2 biomarkers can help predict end-stage renal disease

3D capillary device can increase production of high-quality liposomes

Olive oil supplements may counteract adverse cardiovascular effects of exposure to air pollution

New ultra-sensitive nano-chip capable of detecting cancer at early stages

OxThera granted new patents for treatment of hyperoxaluria

Environmental researchers call for ban on cigarette filters

Mixing stem cells with clay to regenerate human tissue

Six-way jet-in-air sorter from Beckman Coulter Life Sciences delivers simultaneous high-speed cell sorting and sub-micron particle detection

Retinal measurements associated with Parkinson’s disease duration

NovaBay introduces new eye care product to help patients with eyelids irritation

Sprifermin reduces cartilage loss in patients with knee osteoarthritis

OPKO Health enters into definitive agreement to acquire Inspiro Medical

Quantum Materials supplies metallic oxide particles to major Asian electronics conglomerate

Experts and entrepreneurs to gather at 2014 Biotech China on 14-16 May

Comprehensive genomic analysis of low-grade brain tumors sorts into three categories

Covaris' European subsidiary to commence operations on May 1, 2014

Viewpoints: A 'misguided' debate; trying to figure out who's uninsured; the safety net for the middle class

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News